Li C, Zhang M, Zhao Y, Yang D, Zhao M, Shang L
Int J Mol Sci. 2025; 26(1.
PMID: 39795931
PMC: 11719599.
DOI: 10.3390/ijms26010072.
Suzuki Y, Matsunaga N, Aoyama T, Ogami C, Hasegawa C, Iida S
Clin Transl Sci. 2024; 17(12):e70097.
PMID: 39629510
PMC: 11615510.
DOI: 10.1111/cts.70097.
Merrigan S, Kish-Trier E, Seegmiller J, Johnson-Davis K
Clin Mass Spectrom. 2024; 3:41-48.
PMID: 39193102
PMC: 11322753.
DOI: 10.1016/j.clinms.2017.07.001.
Aravamudhan A, Johnson C, Seegmiller J
Methods Mol Biol. 2023; 2737:329-336.
PMID: 38036834
DOI: 10.1007/978-1-0716-3541-4_30.
Bello K, Lorch G, Kim K, Toribio R, Yan L, Xie Z
J Vet Intern Med. 2023; 37(5):1907-1916.
PMID: 37469186
PMC: 10472989.
DOI: 10.1111/jvim.16797.
Development and application of a thin-film molecularly imprinted polymer for the measurement of mycophenolic acid in human plasma.
Langille E, Bottaro C
J Clin Lab Anal. 2023; 37(6):e24864.
PMID: 37032424
PMC: 10156102.
DOI: 10.1002/jcla.24864.
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.
Russell M, Dey M, Flint J, Davie P, Allen A, Crossley A
Rheumatology (Oxford). 2022; 62(4):e48-e88.
PMID: 36318966
PMC: 10070073.
DOI: 10.1093/rheumatology/keac551.
Immunomodulatory treatment of interstitial lung disease.
Van den Bosch L, Luppi F, Ferrara G, Mura M
Ther Adv Respir Dis. 2022; 16:17534666221117002.
PMID: 35938712
PMC: 9364223.
DOI: 10.1177/17534666221117002.
Sustained suppression of enterohepatic circulation of mycophenolic acid by antimicrobial-associated diarrhea in a kidney transplant recipient with Crohn's disease: A case report.
Tanaka R, Matsumoto A, Tatsuta R, Ando T, Shin T, Mimata H
Clin Case Rep. 2022; 10(6):e05914.
PMID: 35677857
PMC: 9167663.
DOI: 10.1002/ccr3.5914.
Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients: A Comparison of the Early and Stable Posttransplant Stages.
Wang P, Xie H, Zhang Q, Tian X, Feng Y, Qin Z
Front Pharmacol. 2022; 13:859351.
PMID: 35614937
PMC: 9126255.
DOI: 10.3389/fphar.2022.859351.
Antiproliferatives and Transplantation.
Donovan R, Eisen H, Ali O
Handb Exp Pharmacol. 2021; 272:39-52.
PMID: 34697667
DOI: 10.1007/164_2021_556.
Acute Mycophenolate Mofetil Overdose Managed Conservatively.
Sharma P, Guragain A, Adhikari S, Dahal S, Dhungana B
Cureus. 2021; 13(8):e17417.
PMID: 34589327
PMC: 8459915.
DOI: 10.7759/cureus.17417.
The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients.
AbdElhalim M, Kenawy A, Demellawy H, Azouz A, Alghanem S, Al-Otaibi T
Kidney Res Clin Pract. 2020; 39(4):479-486.
PMID: 33214342
PMC: 7770995.
DOI: 10.23876/j.krcp.20.059.
Recent advances in the management of non-infectious posterior uveitis.
Singh R, Sinha S, Saini C, Elbasiony E, Thakur S, Agarwal A
Int Ophthalmol. 2020; 40(11):3187-3207.
PMID: 32617804
DOI: 10.1007/s10792-020-01496-0.
A Limited Sampling Strategy for Therapeutic Drug Monitoring of Mycophenolate Mofetil for Prophylaxis of Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Transplantation.
Gota V, Purohit V, Gurjar M, Nayak L, Punatar S, Gokarn A
Cell Transplant. 2020; 29:963689720912925.
PMID: 32495641
PMC: 7444217.
DOI: 10.1177/0963689720912925.
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation.
Klaasen R, Bergan S, Bremer S, Hole K, Nordahl C, Andersen A
Br J Clin Pharmacol. 2020; 86(6):1100-1112.
PMID: 31925806
PMC: 7256122.
DOI: 10.1111/bcp.14218.
Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention.
Metz D, Holford N, Kausman J, Walker A, Cranswick N, Staatz C
Transplantation. 2019; 103(10):2012-2030.
PMID: 31584924
PMC: 6756255.
DOI: 10.1097/TP.0000000000002762.
Adverse effects of mycophenolic acid in renal transplant recipients: gender differences.
Spasic A, Catic-dordevic A, Velickovic-Radovanovic R, Stefanovic N, Dzodic P, Cvetkovic T
Int J Clin Pharm. 2019; 41(3):776-784.
PMID: 31028595
DOI: 10.1007/s11096-019-00837-z.
Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.
Tague L, Byers D, Hachem R, Kreisel D, Krupnick A, Kulkarni H
Pharmacogenomics J. 2019; 20(1):69-79.
PMID: 30992538
PMC: 6800829.
DOI: 10.1038/s41397-019-0086-0.
The utility of trough mycophenolic acid levels for the management of lupus nephritis.
Pourafshar N, Karimi A, Wen X, Sobel E, Pourafshar S, Agrawal N
Nephrol Dial Transplant. 2018; 34(1):83-89.
PMID: 29548021
PMC: 6657446.
DOI: 10.1093/ndt/gfy026.
